The immunotherapy drug pembrolizumab will be available to those with incurable forms of the disease immediately after it won the green light from the National Institute for Health and Care Excellence (Nice), the drugs regulator. Currently, two women with the disease die every day. The Guardian
See also:
- Hundreds of people are set to receive the first immunotherapy drug for advanced cervical cancer through the Cancer Drugs Fund National Institute for Health and Care Excellence
- First new life-extending NHS treatment for incurable cervical cancer in almost 15 Years NHS England
- NHS will offer pembrolizumab cervical cancer drug in England BBC News
- Patients with incurable cervical cancer offered life-extending drug The Independent
No comments:
Post a Comment